C Mehle

523 total citations
12 papers, 469 citations indexed

About

C Mehle is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, C Mehle has authored 12 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Oncology. Recurrent topics in C Mehle's work include Telomeres, Telomerase, and Senescence (4 papers), Cancer Genomics and Diagnostics (3 papers) and DNA Repair Mechanisms (2 papers). C Mehle is often cited by papers focused on Telomeres, Telomerase, and Senescence (4 papers), Cancer Genomics and Diagnostics (3 papers) and DNA Repair Mechanisms (2 papers). C Mehle collaborates with scholars based in Sweden. C Mehle's co-authors include Göran Roos, Börje Ljungberg, Kari Remes, Karin Nylander, Peter Nilsson, Roger Stenling, Per Anders Nilsson, Jerry W. Shay, Mieczyslaw A. Piatyszek and Jack Lindh and has published in prestigious journals such as British Journal of Cancer, BMC Infectious Diseases and Genes Chromosomes and Cancer.

In The Last Decade

C Mehle

11 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Mehle Sweden 9 274 243 97 65 64 12 469
Öonagh Loughran United Kingdom 7 117 0.4× 308 1.3× 251 2.6× 49 0.8× 24 0.4× 8 464
Juan Albanell United States 7 334 1.2× 242 1.0× 70 0.7× 43 0.7× 19 0.3× 8 539
Steffen Heeg Germany 11 62 0.2× 273 1.1× 240 2.5× 35 0.5× 60 0.9× 26 509
Akihiro Imada Japan 5 88 0.3× 151 0.6× 86 0.9× 22 0.3× 130 2.0× 7 399
R. Nakashio Japan 5 306 1.1× 189 0.8× 63 0.6× 100 1.5× 37 0.6× 10 459
Toshinori Ide Japan 7 396 1.4× 229 0.9× 60 0.6× 109 1.7× 32 0.5× 9 504
Shigefumi Hayashi Japan 12 356 1.3× 212 0.9× 57 0.6× 62 1.0× 27 0.4× 16 506
Michael Frost United States 8 86 0.3× 215 0.9× 173 1.8× 39 0.6× 32 0.5× 11 400
Vali A. Papadimitrakopoulou United States 7 16 0.1× 130 0.5× 116 1.2× 33 0.5× 45 0.7× 10 292
Yaoshu Teng China 10 51 0.2× 177 0.7× 243 2.5× 8 0.1× 34 0.5× 32 523

Countries citing papers authored by C Mehle

Since Specialization
Citations

This map shows the geographic impact of C Mehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Mehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Mehle more than expected).

Fields of papers citing papers by C Mehle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Mehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Mehle. The network helps show where C Mehle may publish in the future.

Co-authorship network of co-authors of C Mehle

This figure shows the co-authorship network connecting the top 25 collaborators of C Mehle. A scholar is included among the top collaborators of C Mehle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Mehle. C Mehle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
3.
Remes, Kari, et al.. (2000). Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. British Journal of Cancer. 82(3). 601–607. 37 indexed citations
4.
Ljungberg, Börje, et al.. (1999). Clinical significance of nm23 expression in renal cell carcinoma. Urological Research. 27(2). 103–107. 4 indexed citations
5.
Mehle, C, Annika Lindblom, Börje Ljungberg, Roger Stenling, & Göran Roos. (1998). Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.. International Journal of Oncology. 13(2). 289–95. 16 indexed citations
6.
Nylander, Karin, et al.. (1996). A non-random deletion in the p53 gene in oral squamous cell carcinoma. British Journal of Cancer. 73(11). 1381–1386. 22 indexed citations
7.
Ljungberg, Börje, C Mehle, Roger Stenling, & Göran Roos. (1996). Heterogeneity in renal cell carcinoma and its impact on prognosis - a flow cytometric study. British Journal of Cancer. 74(1). 123–127. 58 indexed citations
8.
Mehle, C, Mieczyslaw A. Piatyszek, Börje Ljungberg, Jerry W. Shay, & Göran Roos. (1996). Telomerase activity in human renal cell carcinoma.. PubMed. 13(1). 161–6. 82 indexed citations
9.
Nylander, Karin, Per Anders Nilsson, C Mehle, & Göran Roos. (1995). p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. British Journal of Cancer. 71(4). 826–830. 67 indexed citations
10.
Mehle, C, Börje Ljungberg, & Göran Roos. (1994). Telomere shortening in renal cell carcinoma.. PubMed. 54(1). 236–41. 89 indexed citations
11.
Nilsson, Peter, C Mehle, Kari Remes, & Göran Roos. (1994). Telomerase activity in vivo in human malignant hematopoietic cells.. PubMed. 9(10). 3043–8. 78 indexed citations
12.
Mehle, C, et al.. (1993). DNA fingerprinting of renal cell carcinoma with special reference to tumor heterogeneity. Genes Chromosomes and Cancer. 6(2). 86–91. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026